The global cardiac rehabilitation market size was valued at USD 1.46 billion in 2016 and is expected to grow at a CAGR of 6.3% over the forecast period. This growth can be attributed to dynamic technological innovations and advancements. Tele-cardiac rehabilitation is a term used to define rehabilitation services provided from a distance using information technology and telecommunications. Tele-cardiac rehabilitation potentially minimizes barriers of time, distance, and cost. e-cardiology and e-health have evolved considerably over the past years and are expected to influence cardiovascular disease management and prevention in the near future.
Supportive government interventions are considered as one of the high impact rendering drivers of this market. For instance, the Million Hearts is a national initiative co-led by the Centers for Disease Control and Prevention and Centers for Medicare and Medicaid Services. The objective of this initiative is to prevent over one million strokes and heart attacks by 2017. This initiative brings together new and existing programs to improve health of American citizens and help them live longer and healthier.
Rising incidence of lifestyle-associated diseases such as cardiovascular diseases, diabetes, and obesity contribute majorly to the growth of cardiac rehabilitation globally. According to the Heart Disease and Stroke Statistics, 2017, a study by the American Heart Association, cardiovascular disease is listed as the underlying cause of deaths, which accounts for nearly 801,000 deaths in the U.S.
On the basis of product type, the cardiac rehabilitation market has been categorized into elliptical trainers, stabilization balls, stationary bicycles, treadmills, rowers, heart rate monitors, blood pressure monitors, and others. Treadmills dominated the segment in 2016 with over 30.0% of the market share.
Factors responsible for the dominant share held by treadmills in the cardiac rehabilitation product segment worldwide includes rise in incidence of lifestyle-associated diseases such as cardiovascular diseases & obesity and increase in number of health and fitness conscious people. A study conducted in 2016 by WHO estimated that around 422.0 million adults in the world were suffering from diabetes in 2014.
The blood pressure monitor segment is anticipated to witness the fastest growth during the forecast period with a CAGR of 9.8%. This growth is expected to be the result of increasing need for real time vital signs monitoring devices. The demand for digital meters is higher than that for traditional manual meters as digital meters are easy-to-use and can be easily stored and transported.
North America dominated the market in 2016 and generated the largest revenue in the cardiac rehabilitation market.The U.S. contributes a major percentage to the cardiovascular disease burden of North America owing to large population and changes in lifestyle. Heart diseases including hypertension, stroke, and coronary heart conditions were estimated to be the foremost cause of deaths in the U.S. in 2016. Cardiac rehabilitation led to a 31.0% decrease in hospital readmissions and a 26.0% drop in cardiovascular mortality, as per a study presented in 2017 at the Canadian Cardiovascular Congress.
On the other hand, MEA and Asia Pacific regions are anticipated to witness fastest growth over the forecast period. This growth is anticipated to be a result of growing infrastructure and adaption of technological innovations. Increase in geriatric population and rise in the number of health and fitness conscious people are factors that increase the demand for cardiac rehabilitation in the global market.
Some of the key players in the market are Ball Dynamics International, LLC, Honeywell International, Inc., Core Health & Fitness, LLC, LifeWatch, Philips, Amer Sports, Smiths Group, OMRON Corporation, Halma plc, and Brunswick Corporation.
These key players undertake various strategic initiatives such as collaborations, new product launches, and mergers & acquisitions.
For instance, in January 2017, Halma plc acquired FluxData, which designs and manufactures advanced digital and multispectral imaging systems for various sectors such as industrial and medical sectors. This is anticipated to help the company expand its product portfolio and increase its overall net sales in the next fiscal year.
On July 21, 2015, Amer Sports acquired Queenax, a leading functional training systems provider. This acquisition is anticipated to strengthen the fitness product and service offering of Amer Sports, thus expanding its product portfolio. This acquisition includes the brand name-Queenax-and distribution & intellectual property rights. The acquisition is expected to enable Precor to offer a complete functional training system to its customers and strengthen its position as one of the leading players in the global cardiac rehabilitation service and fitness equipment markets.
Attribute |
Details |
Base year for estimation |
2016 |
Actual estimates/Historical data |
2014 - 2016 |
Forecast period |
2017 - 2025 |
Market representation |
Revenue in USD Million & CAGR from 2017 to 2025 |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, UK, Germany, France, Japan, China, India, Brazil, Mexico, Saudi Arabia, and South Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
15% free customization scope (equivalent to 5 analysts working days) |
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the cardiac rehabilitation market on the basis of product and region:
Products (Revenue, USD Million, 2014 - 2025)
Elliptical trainer
Stabilization ball
Stationary bicycle
Treadmill
Rower
Heart rate monitor
Blood pressure monitor
Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S
Canada
Europe
UK
Germany
Italy
Spain
France
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East and Africa (MEA)
South Africa
Saudi Arabia
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.